NVAX
NVAX
NASDAQ · Biotechnology

Novavax Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$9.62
-0.12 (-1.23%)
As of Mar 22, 10:09 PM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 10 67%
Hold 2 13%
Sell 3 20%
Price Target
Analyst Price Target +200.2% upside
Low Target $20.35
Average Target $28.88
High Target $29.25
Current Price $9.62
Current
$9.62
Target
$28.88
$20.35 $28.88 avg $29.25
Scenario Analysis
Bear Case
$20.35
111.5%
Low target
Base Case
$28.88
+200.2%
Avg target
Bull Case
$29.25
+204.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$11.97
-19.6% from high
52-Week Low
$5.01
+92.0% from low
Target vs 52W High
$28.88
+141.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%